This trial is testing lenvatinib and pembrolizumab as a possible treatment for kidney cancer that has spread to nearby tissues or lymph nodes.
- Stage IV Renal Cell Carcinoma
- Kidney Cancer
- Stage III Renal Cell Carcinoma
1 Primary · 3 Secondary · Reporting Duration: Up to 4 years after study start
1 Treatment Group
Treatment (lenvatinib, pembrolizumab)
1 of 1
22 Total Participants · 1 Treatment Group
Primary Treatment: Pembrolizumab · No Placebo Group · Phase 2
Who is running the clinical trial?
Age 18+ · All Participants · 10 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
To what degree is Pembrolizumab risky for participants?
"While there is some proof of Pembrolizumab's safety, the lack of data demonstrating efficacy has led to a score of 2 being assigned." - Anonymous Online Contributor
What medical conditions does Pembrolizumab usually address?
"Pembrolizumab has been shown to be effective for treating malignant neoplasms, unresectable melanoma, and microsatellite instability high." - Anonymous Online Contributor
What other clinical experimentation has been conducted using Pembrolizumab?
"Currently, 1033 clinical trials are researching the effects and efficacy of Pembrolizumab. Of these studies 134 have reached Phase 3 while Sacramento is home to many of the sites conducting this research; 37103 locations across the globe are taking part in studying Pembrolizumab." - Anonymous Online Contributor
What is the upper limit of subjects taking part in this investigation?
"That's correct. As evidenced on clinicaltrials.gov, this medical trial is currently enrolling participants and the initial posting was made June 22nd 2020 with a final edit taking place November 28th 2022. A total of 22 individuals are being sought out from one research centre." - Anonymous Online Contributor
Are there any vacancies left in this clinical investigation?
"Affirmative. Clinicaltrials.gov data indicates that this research endeavor is still welcoming participants, having initially been posted on June 22nd 2020 and most recently updated on November 28th 2022. The study requires the enrollment of 22 individuals from a single medical facility." - Anonymous Online Contributor